跳至主要内容
临床试验/NCT04338633
NCT04338633Unknown不适用

Post-operative Pain Reduction After Application of Three Intracanal Medicament Within Necrotic Root Canals and Pulp

Minia University1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2020年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
发起方
入组人数
30
试验地点
1
主要终点
change in post operative pain (Visual Analogue Scale)

研究概览

简要总结

Recruited patients with necrotic pulp after application of conventional calcium hydroxide paste are assigned to group, Calcium hydroxide nanoparticle group and Combined Calcium hydroxide with silver nanoparticle group and record postoperative pain afterwards.

详细描述

The investigator will recruit patients who are found eligible to the criteria, conventional calcium hydroxide paste , Calcium hydroxide nanoparticle and Combined Calcium hydroxide with silver nanoparticle . After 48 hours, patients will be randomly assigned to removal of intracanal medication

After the visit, patients will be asked to record post operative pain by Numerical Rating Scale)in a given sheet

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

盲法说明

double

入排标准

年龄范围
25 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • • Medically free patients.
  • Patient's age between 25-50 years.
  • Sex includes both male and female.
  • Radiographic evidence of a periapical radiolucent lesion associated with tooth.
  • Necrotic pulp as indicated by thermal pulp testing.
  • No history of previous endodontic treatment of the tooth.

排除标准

  • • Teeth with unfavorable conditions for rubber-dam application.
  • Teeth with acute periapical abscesses swelling.
  • Medically compromised patients.
  • Immature teeth with open apices.
  • Multi rooted teeth.
  • Pregnant women.

研究组 & 干预措施

Conventional calcium hydroxide paste

Active Comparator

Application of Conventional calcium hydroxide paste

干预措施: Conventional calcium hydroxide paste (Drug)

Calcium hydroxide nanoparticle

Experimental

Application of Calcium hydroxide nanoparticle

干预措施: Calcium hydroxide nanoparticle (Drug)

Combined Calcium hydroxide with silver nanoparticle

Experimental

Application of Combined Calcium hydroxide with silver nanoparticle

干预措施: Combined Calcium hydroxide with silver nanoparticle (Drug)

结局指标

主要结局

change in post operative pain (Visual Analogue Scale)

时间窗: Intrappointment at 4,24,48,72 and 96 hours ]

Numerical (0-10)

次要结局

未报告次要终点

研究者

发起方
Minia University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Mohamed Salah Mohamed Fahmy

PHD Candidate - Endodontic Department- Faculty of Dentistry

Minia University

研究点 (1)

Loading locations...

相似试验